Diagnostic Performance of Endocytoscopy for Colorectal Lesions

Launched by THE FIRST HOSPITAL OF JILIN UNIVERSITY · May 1, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new method called endocytoscopy to help doctors better understand colorectal lesions, which are abnormal growths in the colon or rectum. Colorectal cancer is a serious health issue, and finding and removing these lesions early can greatly improve patient outcomes. The trial aims to evaluate how effective endocytoscopy is for diagnosing these lesions compared to traditional methods. This technique allows doctors to see tiny details of the lesions, which can help them decide if further treatment is needed, potentially reducing the need for additional tests and procedures.

To participate in the trial, you must have colorectal lesions, but there are some criteria that might exclude you, such as having a history of certain bowel diseases or specific types of tumors. Participants will undergo an endocytoscopy procedure, where doctors will use special technology to closely examine the lesions. The study is currently recruiting participants of all ages and genders. If you or a loved one is facing colorectal lesions, this trial could be an opportunity to contribute to important research while receiving potentially valuable diagnostic evaluation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • colorectal lesions
• Exclusion Criteria:
• • non-epithelial tumors
• • a history of inflammatory bowel disease
• • lesions without clear EC images
• • specific pathological types
• • familial adenomatous polyposis